Exposing ExxonMobil and Winning $725.5 Million, with Andrew DuPont

Just Verdicts

Gasoline is refined from crude oil that contains benzene, a known carcinogen, but oil companies have long considered removing benzene from the gasoline manufacturing process a “dollars-and-cents” decision. Jurors considering whether ExxonMobil’s gasoline caused a Pennsylvania man’s leukemia made this decision: $725.5 million for the plaintiff.

Andrew DuPont, partner at Locks Law Firm, won that verdict by framing his argument as ExxonMobil’s failure to warn consumers about benzene’s health hazards, even though its dangers were known by the time his client was using gasoline as a solvent to clean automotive parts in the 1970s. Breaking down complex scientific evidence in a way that would stick with the jury, Andrew fended off ExxonMobil’s defense that “gasoline’s not benzene, gasoline doesn’t cause cancer.” Tune in to hear Andrew share his successful strategy with host Brendan Lupetin.

Learn More and Connect

☑️ Andrew J. DuPont | LinkedIn | Email

☑️ Locks Law Firm on Facebook | LinkedIn | X | YouTube

☑️ Brendan Lupetin | LinkedIn

☑️ Lupetin & Unatin, LLC

☑️ Connect: Facebook | LinkedIn | YouTube

☑️ Subscribe: Apple Podcasts | Spotify | YouTube

Episode Preview

• The history behind benzene and its link to cancer
• How defendants try to distract jurors in cases involving benzene exposure
• How the oil and gasoline industry protects profits over people
• The background of Andrew’s case against ExxonMobil and his $725 million verdict
• How Andrew leveraged ExxonMobil’s “significant mistake” in its opening statement

Ready to refer or collaborate on med mal, medical negligence, and catastrophic injury cases? Visit our attorney referral page at PAMedMal.com/Refer. We handle cases in Pennsylvania and across the United States.